Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Total Debt: 2011-2019

Historic Total Debt for EyePoint Pharmaceuticals (EYPT) over the last 1 years, with Mar 2019 value amounting to $32.0 million.

  • EyePoint Pharmaceuticals' Total Debt rose 148.65% to $32.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $32.0 million, marking a year-over-year increase of 148.65%. This contributed to the annual value of $17.3 million for FY2018, which is N/A change from last year.
  • According to the latest figures from Q1 2019, EyePoint Pharmaceuticals' Total Debt is $32.0 million, which was up 81.33% from $17.6 million recorded in Q4 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Total Debt registered a high of $32.0 million during Q1 2019, and its lowest value of $12.8 million during Q1 2018.
  • For the 2-year period, EyePoint Pharmaceuticals' Total Debt averaged around $19.4 million, with its median value being $17.5 million (2018).
  • Data for EyePoint Pharmaceuticals' Total Debt shows a peak YoY surged of 148.65% (in 2019) over the last 5 years.
  • Over the past 2 years, EyePoint Pharmaceuticals' Total Debt (Quarterly) stood at $17.6 million in 2018, then skyrocketed by 148.65% to $32.0 million in 2019.
  • Its last three reported values are $32.0 million in Q1 2019, $17.6 million for Q4 2018, and $17.5 million during Q3 2018.